| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |